Pimavanserin metabolite (ac-271628)

2-(4-chlorophenyl)-N-(2H-indazol-6-yl)ethene-1-sulfonamide

1H-Indazole-6,7-diamine

rel-2-Chloro-6-fluoro-N-[(1R,2R)-2-hydroxycyclohexyl]-N-methylbenzenemethanesulfonamide

4-(4-Methoxyphenoxy)quinoline

3-[1-[5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-hydroxyoxolan-2-yl]-2,4-dioxopyrimidin-5-yl]-N-[6-[(2,2,2-trifluoroacetyl)amino]hexyl]prop-2-enamide

3-methyl-2-[(4-methylbenzyl)sulfanyl]thieno[3,2-d]pyrimidin-4(3H)-one

(2R,3R,4R,5R)-5-(6-Amino-2-fluoro-9H-purin-9-yl)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-methoxytetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite

(2R,3R,4R,5R)-5-(6-Amino-2-fluoro-9H-purin-9-yl)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-((tert-butyldimethylsilyl)oxy)tetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite

(2R,3S,5R)-5-(6-Amino-2-fluoro-9H-purin-9-yl)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)tetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite

Tetrahydro-3-methyl-2H-1,3-thiazine